Chemoprophylaxis refers to the use of chemical agents, such as drugs or medications, to prevent the development or spread of infectious diseases. This proactive approach is often employed in situations where the risk of infection is high, such as during outbreaks or in specific populations with increased vulnerability. Common examples of chemoprophylaxis include the use of antibiotics to prevent bacterial infections, antimalarial drugs for travelers visiting regions with malaria, and antiviral medications for preventing certain viral infections. The choice of the chemoprophylactic agent depends on the specific pathogen and the characteristics of the population at risk. Chemoprophylaxis is widely utilized in public health strategies, such as in the prevention of sexually transmitted infections, tuberculosis, and certain parasitic diseases. The effectiveness of chemoprophylaxis relies on factors like the timing of administration, compliance with the prescribed regimen, and the emergence of drug resistance. While chemoprophylaxis is a valuable tool in disease prevention, its use requires careful consideration of factors such as potential side effects, the development of resistance, and the overall impact on public health. Proper education, monitoring, and adherence to guidelines are crucial for the success of chemoprophylaxis programs.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India